Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 167,806 | 37,797 | 39,545 | 298,172 | 89,959 |
| Marketable Securities | 147,551 | 50,553 | 62,881 | 29,312 | 83,506 |
| Receivables | 95,539 | 68,440 | 17,474 | 16,785 | 14,065 |
| Other current assets | 0 | 0 | 2,038 | 1,513 | 53,779 |
| TOTAL | $418,460 | $161,067 | $133,541 | $353,464 | $249,870 |
| Non-Current Assets | |||||
| PPE Net | 5,895 | 7,418 | 9,068 | 11,875 | 13,657 |
| Investments And Advances | 11,128 | 0 | 0 | 0 | 67,537 |
| Other Non-Current Assets | 50,087 | 185,676 | 239,390 | 242,061 | 43,755 |
| TOTAL | $67,110 | $193,094 | $248,458 | $253,936 | $124,949 |
| Total Assets | $485,570 | $354,161 | $381,999 | $607,400 | $374,819 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 16,940 |
| Accounts payable and accrued liabilities | 2,568 | 2,242 | 1,524 | 1,554 | 3,098 |
| Accrued Expenses | 14,644 | 10,006 | 9,343 | 14,334 | 19,634 |
| Other current liabilities | N/A | N/A | 6,490 | N/A | N/A |
| TOTAL | $38,302 | $32,085 | $24,767 | $28,715 | $58,587 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 371,359 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 98 |
| Other Non-Current Liabilities | 150,545 | 146,531 | 144,237 | 136,693 | 283,136 |
| TOTAL | $150,545 | $146,531 | $144,237 | $136,885 | $654,805 |
| Total Liabilities | $188,847 | $178,616 | $169,004 | $165,600 | $713,392 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,493 | 49,471 | 48,165 | 62,864 | 74,697 |
| Common Shares | 1 | N/A | N/A | 1 | 1 |
| Retained earnings | -859,627 | -965,522 | -909,104 | -853,911 | -1,726,043 |
| Other shareholders' equity | 61 | 7 | -65 | -15 | 0 |
| TOTAL | $296,723 | $175,545 | $212,995 | $441,800 | $-338,573 |
| Total Liabilities And Equity | $485,570 | $354,161 | $381,999 | $607,400 | $374,819 |